| Characteristic | Phase I | Phase II | Phase III |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
May 2019
Region
Worldwide
Survey time period
2008 through 2017
Supplementary notes
A total of 862 clinical trial starts were retrieved from TrialTrove. Trials were individually assessed for disease modifying vs. symptom modifying drugs and trial phase cohorts de-duplicated. A total of 170 novel drug intervention trials were initiated during this time period.
Citation formats









